You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Company News
Company News Brief News on Innovation
Company News
PEIJIA MEDICAL ANNOUNCED  UNAUDITED 2023 ANNUAL RESULTS
2024.03.29
PEIJIA MEDICAL ANNOUNCED UNAUDITED 2023 ANNUAL RESULTS

On March 28, 2024, Peijia Medical announced that it would delay the publication ···
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECEMBER 31, 2023
2024.01.26
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECE···

This announcement is made by Peijia Medical Limited (the “Company”, together wit···
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference
2023.10.31
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference

Transcatheter Cardiovascular Therapeutics 2023 (TCT 2023) conference, the annual···
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE 30, 2023
2023.07.24
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE ···

UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEMBER 31, 2022
2023.01.18
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEM···

Peijia Medical Announced 2021 Annual Results
2022.04.06
Peijia Medical Announced 2021 Annual Results

On March 31, 2022, Peijia Medical Limited (“Peijia Medical” or the “Company”, to···
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR System for Treating AR in  the Greater China Region
2022.02.07
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR Sy···

Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investm···
Peijia Medical Announces 2021 Interim Results
2021.08.31
Peijia Medical Announces 2021 Interim Results

Peijia Medical Announces 2021 Interim ResultsTAVR products TaurusOne® and T···
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) P
2021.06.10
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricu···

Peijia Medical (HKEX:9996, or “Peijia”), a leading player in China for medical t···
Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation
2021.06.04
Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation

Peijia Medical Limited signed a memorandum of strategic cooperation with China R···
Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped Market and Supports
2020.12.21
Collaboration Strengthens Peijia’s Position for Competing in a Largely Unta···

BEIJING and PARIS, December 21, 2020 — Peijia Medical Ltd (HK Stock Code: 09996)···
Peijia Medical Successfully Listed on the Main Board of the Stock Exchange of Hong Kong
2020.05.15
Peijia Medical Successfully Listed on the Main Board of the Stock Exchange ···

Not for distribution, directly or indirectly, in or into the United StatesThis p···
Top